Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Catalyst Pharmaceuticals, Inc. (CPRX) had Consolidated Net Income/Loss of $52.11M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$146.56M |
|
$52.11M |
|
$20.61M |
|
$125.95M |
|
$80.27M |
|
$66.30M |
|
$3.00M |
|
$69.29M |
|
$69.29M |
|
$52.11M |
|
$52.11M |
|
|
Consolidated Net Income/Loss |
$52.11M |
$52.11M |
|
$66.30M |
|
$75.76M |
|
122.16M |
|
127.54M |
|
$0.43 |
|
$0.41 |
|
| Balance Sheet Financials | |
$758.74M |
|
$1.15M |
|
$213.18M |
|
$971.91M |
|
$113.01M |
|
-- |
|
$2.88M |
|
$115.89M |
|
$856.03M |
|
$718.04M |
|
$856.03M |
|
122.39M |
|
| Cash Flow Statement Financials | |
$131.34M |
|
$-0.03M |
|
$3.93M |
|
$517.55M |
|
$652.80M |
|
$135.25M |
|
$13.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.94% |
|
45.24% |
|
45.24% |
|
-- |
|
47.28% |
|
35.55% |
|
$131.31M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
1.11 |
|
2.23 |
|
40.44 |
|
6.09% |
|
7.26% |
|
5.36% |
|
6.09% |
|
$6.99 |
|
$1.03 |
|
$1.03 |
|